Now showing items 1-3 of 3

    • The appropriateness of WHO influenza B vaccine component to Kenya in 2011-2012 

      Ocholla, S; Jumba, G; Bulimo, W; Achilla, R; Wadegu, MO; Mukunzi, S; Majanja, JM; Opot, B; Osuna, F; Muthoni, J; Njiri, J; Mwangi, J; Kibet, K; Coldren, R (University of Nairobi, 2014)
      Background: In the 1980’s, influenza B viruses were discovered to belong to two evolutionary groupings (B/Victoria/2/87-like viruses and B/Yamagata/16/88-like viruses) that continue to co-circulate globally in the human ...
    • Characterization Of Neuraminidase Inhibitor Susceptibility Of Influenza A Isolates Obtained In Kenya, 2008-2011 

      Wadegu, M; Bulimo, W; Achilla, R; Mukunzi, S; Majanja, J; Opot, B; Osuna, F; Muthoni, J; Njiri, J; Mwangi, J; Kibet, K; Ocholla, S; Wurapa, E (University of NairobiSchool of Medicine, 2013)
      Background: Vaccines and antivirals are the mainstay for mitigation and clinical management of influenza infections. However, due to the ever-changing antigenic profile, vaccine formulations are revised every year to make ...
    • Seasonal trend of Influenza in Kenya from January - October 2013 

      Majanja, J; Bulimo, W; Achilla, R; Wadegu, M; Mukunzi, S; Njiri, J; Mitei, K; Opot, B; Ocholla, S; Mwangi, J; Osuna, F; Coldren, R (University of Nairobi, 2014)
      Background: Influenza A and B viruses cause annual epidemics of respiratory illness. The Influenza surveillance network in Kenya through its sentinel surveillance sites located throughout the country has established that ...